Articles tagged with Retina
Scientists at the University of Augsburg have found that macrophages, also known as scavenger cells, form in the vitreous body of the mouse eye during embryonic development. This new understanding could lead to therapies for diseases like diabetic retinopathy and prenatal vessel defects.
Researchers found that inhibiting telomerase, an enzyme related to cell growth and division, can suppress abnormal vascular growth in the retina. This discovery provides a potential alternative treatment option for wet AMD, which is currently treated with anti-VEGF injections.
Researchers have developed a new treatment for diabetic retinopathy that addresses the root cause of the disease, preventing progression and potential blindness. The anti-ceramide immunotherapy has been shown to be effective in animal and cell culture models, offering a safer alternative to current treatments.
Researchers find that a repurposed drug, crizanlizumab, stabilizes vision in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) after two years of treatment. The study suggests that this may give patients additional years to read, drive, and enjoy activities.
A new soft multi-electrode system for electroretinography has been developed to overcome the limitations of traditional devices. The system uses a commercially available soft disposable contact lens with gold mesh electrodes, allowing for simultaneous measurement of electrical potentials from different regions of the retina. This innov...
A pioneering CRISPR gene editing trial has demonstrated significant improvement in vision for 79% of participants with inherited retinal degeneration. The study's findings support further research into the potential of CRISPR-based treatments for inherited blindness.
A phase 1/2 trial of CRISPR gene editing has demonstrated safety and efficacy, with measurable improvements in 11 out of 14 participants with a form of inherited blindness. The treatment, EDIT-101, was found to be clinically meaningful for four participants and showed significant improvements in cone-mediated vision.
A team of researchers from the University of Rochester used adaptive optics to identify rare retinal ganglion cells that could help explain how humans perceive color. These non-cardinal RGCs may work in tandem with cardinal RGCs to create more complex color perceptions.
Researchers from the University of Rochester found that blinking allows brains to process visual information more effectively, providing a new understanding of how humans see. By modulating visual input, blinks reformulate visual signals, enabling better perception of big patterns and overall visual scenes.
Researchers at NIH developed a novel AI-based method called P-GAN to improve next-generation imaging of cells in the retina. The technique reduces imaging acquisition and processing time by 100-fold, yielding greater contrast and improving image quality.
A team of scientists from Pohang University of Science & Technology developed an artificial vitreous body based on alginate to treat retinal detachment. The hydrogel maintains vision post-surgery and regulates fluid dynamics within the eye, preventing recurrence and air bubble formation.
Researchers at the University of Alabama at Birmingham discovered that the ALG6 variant is associated with altered phenotypes in patients with RP59, including delayed peripheral rod degeneration and diminished macular cone photoreceptor health. This study highlights the complex effects of modifier genes in human genetic disease.
Researchers have made a breakthrough in developing genetic treatments for hereditary conditions like cystic fibrosis and inherited vision loss. They created a new type of lipid nanoparticle, called Thio-lipids, that can deliver therapeutic payloads to the lungs and retina.
A new study finds that gut bacteria can cause blindness in some inherited eye diseases by breaching the body's defenses. Treating these bacteria with antimicrobials may prevent sight loss, offering a potential new approach to treatment.
A new study published in JAMA Ophthalmology suggests that artificial intelligence can match or exceed the expertise of seasoned ophthalmic specialists in diagnosing and treating patients with glaucoma and retina disorders. The AI system, GPT-4, demonstrated superior performance in response to glaucoma questions and case-management advice.
Researchers at Mount Sinai Health System developed a novel protocol for rapid diagnosis of eye stroke, improving outcomes and preserving vision. The protocol uses high-resolution retinal imaging in emergency rooms, along with remote consultation, to confirm diagnosis and expedite care.
Researchers developed a machine learning framework that encodes images like a retina, reducing sensory encoding challenges in neural prostheses. The actor-model approach produced images eliciting a neuronal response more akin to the original image response.
Studies on knockout mice have shown that removal of specific matrix proteins leads to visual deficits, including impaired motion processing and synaptic imbalance. This research contributes to a better understanding of visual processing mechanisms, potentially offering new therapeutic approaches.
A University of Houston optometry researcher has warned against using low-level red light therapy for myopia in children due to potential retinal damage. The therapy, which involves prolonged exposure to a red light-emitting instrument, can put the retina at risk of photochemical and thermal damage.
Researchers used fMRI to assess brain responses to lights stimulating only cone cells in dogs with different types of retinal diseases. The study found that gene augmentation therapy restored response in cortex to black and white stimulation, making this disease a promising one for photoreceptor cell replacement treatment.
Researchers found that intrinsically-photosensitive retinal ganglion cells (ipRGCs) use both microvillous and ciliary signaling mechanisms simultaneously. This discovery reveals a new pathway for transmitting light signals to the brain, which may have ancient origins on the evolutionary scale.
A study combines retinal imaging, genetics, and big data to estimate the likelihood of developing eye and systemic diseases. The researchers identified significant associations between retinal layer thickness and increased risk of various diseases, including ocular, neuropsychiatric, cardiac, metabolic, and pulmonary diseases.
Researchers discovered how an offshoot of vitamin A generates the cells that enable people to see millions of colors. The study found that a molecule called retinoic acid determines whether a cone will specialize in sensing red or green light, making humans uniquely color-savvy.
Researchers used OCTA to visualize retinal blood vessel changes in migraine patients during and between attacks. Blood flow decreases were found, with asymmetrical flow correlated to headache pain side.
Researchers identified Elovanoid-34, a molecule that modulates the activity of TXNRD1 protein, which regulates antioxidant defenses. This discovery opens new therapeutic avenues for degenerative brain and eye diseases, as well as promoting healthy aging.
Researchers used AI to analyze electroretinogram signals from children's eyes, identifying unique features associated with autism spectrum disorder (ASD). The test, completed within 10 minutes, shows promise for diagnosing ASD more accurately and efficiently than current methods.
Researchers develop a versatile imaging system for targeted spectroscopy in the eye fundus, allowing for continuous color imaging and spectral measurements. The system enables users to select targets and move them to any location within the eye fundus region without realignment or fixation changes.
A diagnostic study of 1,890 eyes supports the use of artificial intelligence in screening for autism spectrum disorder (ASD) and assessing symptom severity. Retinal photographs may improve accessibility to specialized assessments by reducing resource strain.
Researchers found that most cell types in the retina are ancient and conserved across species, indicating a complex retina in the last common ancestor of all mammals. The study suggests that some cell types have been remodeled or repurposed over time to adapt to different visual needs.
Researchers have developed an AI-powered system to diagnose autism spectrum disorder (ASD) in children using a single flash of light to the eye. The system uses electroretinography (ERG) to identify specific features that classify ASD, providing a faster and more accurate method for diagnosis than existing tests.
Scientists at Johns Hopkins Medicine have identified a molecular pathway involving oxidative stress and the protein HIF-1 that contributes to both wet and dry age-related macular degeneration. Researchers found that while HIF-1 promotes blood vessel growth in retinal cells, it also protects against cell death in advanced dry AMD.
Researchers used 3D eye scans to detect changes in the retina and monitor kidney health, finding that thinner retinas correlated with declining kidney function. The technology has potential to support early diagnosis and aid lifestyle changes to reduce health complications.
Researchers have successfully converted human retinal cells, specifically Muller glia, into neurons in a lab setting using an artificial fish-like genetic program. This breakthrough could potentially serve as a new source of neurons to treat vision loss caused by disease or trauma.
Researchers found that ON pathways are more sensitive in humans but less effective at low light, contributing to myopia progression. Pupil reflexes driven by ON pathways also become weaker, limiting outdoor protection.
A multidisciplinary team at Mass Eye and Ear has identified a promising new strategy for glaucoma cell replacement therapy by guiding stem cells to the retina. The researchers created RGCs out of stem cells and used chemokines to guide them to their correct positions within the retina.
Researchers at Nagoya University identified the link between iron and blindness caused by ocular toxoplasmosis, a parasite affecting one-third of the world's population. Controlling iron levels has shown promise as a potential cure.
Researchers have developed a retina-like biochip that mimics the eye's visual pathways, using conductive polymers and light-sensitive molecules. The chip's non-toxic organic components and flexibility make it suitable for integration into biological systems, paving the way for new treatments for neurological diseases.
A recent human study found that grape consumption improved key markers of eye health in older adults, including increased Macular Pigment Optical Density (MPOD) and reduced AGEs. Regular grape intake was also shown to increase plasma antioxidant capacity and total phenolic content.
A team of researchers at Utah State University has successfully created an in vitro model of Bruch's membrane, a layer in the retina that deteriorates with age. The model uses hagfish slime proteins to replicate the natural aging process and disease progression, providing a valuable tool for studying age-related macular degeneration.
Age-related macular degeneration (AMD) decreases essential fatty acid docosahexaenoic acid (DHA), limiting protective molecule formation and repair potential. The discovery may open new therapeutic avenues for AMD, particularly in females, who are more susceptible to retinal degeneration due to estrogen effects.
A study at the University of Gothenburg found that preterm babies given a supplement with omega-3 and omega-6 fatty acids had improved visual function by age 2.5. The supplement also seemed to improve the brain's ability to interpret visual impressions.
Researchers have successfully transplanted human microglia cells into mouse retina, creating a model for studying treatments for diabetic retinopathy, glaucoma, and age-related macular degeneration. The study demonstrates the potential of microglial replacement therapy to treat retinal and central nervous system diseases.
A study published in Neurology has identified markers of Parkinson's disease in eye scans, detecting the condition up to seven years before clinical presentation. Researchers used AI-powered analysis of retinal images from two large datasets to uncover subtle changes associated with Parkinson's.
A Cochrane review of 17 randomised controlled trials found that blue-light filtering spectacles may not reduce visual fatigue associated with computer use and do not improve sleep quality. The evidence is also unclear on their effects on retinal health.
Researchers from Anglia Ruskin University have successfully grown retinal pigment epithelial cells on a nanofibre scaffold treated with fluocinolone acetonide, showing increased resilience and growth. This breakthrough technology has great potential for developing ocular tissue transplantation to treat age-related macular degeneration.
Researchers at Columbia University Irving Medical Center have discovered that an experimental eye drop treatment can reduce swelling and improve blood flow in the retina of mice with retinal vein occlusion, a common eye disease affecting up to 2% of people over age 40. The study found that the eye drops prevented neurons from deteriora...
Researchers have confirmed that measuring retinal layer thickness can significantly improve MS diagnosis and predict progression. The study found a strong correlation between retinal damage and brain damage, paving the way for earlier treatment and better patient outcomes.
Researchers developed an innovative imaging approach using two-photon microscopy to analyze retinal microcirculation, revealing significant changes in blood flow that may indicate brain diseases. The study suggests that microcirculation in the retina could serve as a promising predictor of cerebrovascular diseases.
Researchers at the University of Georgia found that a diet rich in colorful fruits and vegetables can improve athletes' visual range by acting as a filter to prevent blue light exposure. This improvement can lead to better eye health and functional vision, essential for top athletes in almost any sport.
A new study by Flinders University research team led by Professor Justine Smith has found that women are more likely to experience recurrent cases of toxoplasmosis eye disease. The study also revealed significant differences in the type and characteristics of the disease between men and women.
Researchers have found that stimulating a specific bile acid receptor, FXR, may help prevent retinopathy of prematurity in premature babies. By targeting this receptor, the study aims to develop earlier and more effective treatments to protect their vision.
Researchers developed an experimental drug, 32-134D, that inhibits HIF protein levels, reducing blood vessel production and leakiness in diabetic eyes. The study shows promising results in both human cell models and mice, suggesting a safer therapeutic approach for diabetic eye disease.
Researchers at Brown University have developed a new imaging technique to track changes in blood vessels in the brains of mice, which could lead to early detection of neurodegenerative diseases. The method uses advanced imaging techniques and AI algorithms to identify biomarkers that may predict disease onset.
A diagnostic study using 4,095 retinal fundus images found that biomarker-based AI algorithms can be susceptible to racial bias, even when trained on raw images. This issue highlights the need for careful evaluation of AI performance in diverse populations.
Researchers discovered that a certain short-wave or blue sensitive cone circuit is absent in marmosets and differs from the macaque monkey's circuit. This finding suggests that humans have unique neural wiring for color vision that may be linked to recent evolutionary adaptations.
A deep learning AI model has been developed to screen for retinopathy of prematurity (ROP) in infants at risk of blindness. The tool was trained on images of newborns and found to be as effective as senior paediatric ophthalmologists in discriminating normal retinal images from those with ROP that could lead to blindness.
A study found ChatGPT answered less than half of the test questions correctly, scoring 46% initially and 56% after a month. The AI tool performed well on general medicine questions but struggled with ophthalmology subspecialties.
Researchers have found a new target and drug combination that appears to stop the destruction of vision in premature newborns. By blocking ACAT1, an enzyme that converts cholesterol into smaller pieces, scientists can prevent the formation of leaky blood vessels and inflammation in the retina.
Researchers have built a new model to examine Usher Syndrome, a leading cause of combined deafness and blindness. The model replicates the visual problems not addressed by previous models, offering insight into strategies for designing therapeutic interventions.
Researchers at Duke-NUS Medical School have achieved significant vision recovery in experimental models of damaged retinas using stem cells. The study marks a promising step towards potentially restoring vision in eye diseases characterized by photoreceptor loss.